FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2021983815> ?p ?o ?g. }

• W2021983815 endingPage "69" @default.
• W2021983815 startingPage "63" @default.
• W2021983815 abstract "Background Dithranol (anthralin) has been known to be effective in the treatment of psoriasis for more than 80 years. However, perilesional and uninvolved skin often show irritation during dithranol treatment, which limits its use. As the relapse rate of psoriasis is worsened by adding corticosteroids to a dithranol regimen, the use of topical corticosteroids to reduce dithranol irritation is controversial. Objectives The aim of the present study was to investigate the clinical and cell biological effect of clobetasol‐17‐propionate 0·05% ointment on dithranol‐treated lesional and perilesional skin. Methods For 17 consecutive days, 2% dithranol cream was applied on two test sites. A third site was left untreated on all participating patients (n = 8). All sites consisted of a psoriasis lesion as well as a 3‐cm zone of perilesional skin localized on the back. After 1 h, the cream was washed off, and subsequently one of the dithranol‐treated sites was treated once a day with clobetasol‐17‐propionate 0·05% ointment. The second site was treated once daily with the vehicle. On day 17, punch biopsies were taken from all three lesions and from the perilesional zone of all test sites in order to perform an immunohistochemical investigation, using markers to assess proliferation, differentiation and inflammation. Results The SUM score (erythema + induration + scaling) of the lesion treated with dithranol/clobetasol showed a pronounced reduction, which was significantly greater than the SUM score of the lesion treated with dithranol/vehicle. However, the scores of both sites were equal by 6 weeks of follow‐up. Comparing the two treated lesions, we observed a lower number of cycling epidermal cells in the dithranol/clobetasol lesion and a significantly lower perivascular dermal score of T lymphocytes. Comparing the perilesional skin of the two treated sites we observed less cycling epidermal cells in the dithranol/clobetasol‐treated site. Regarding perilesional differentiation, the interpapillary involucrin expression was higher in the dithranol/clobetasol‐treated site. With respect to perilesional inflammation the expression of dermal polymorphonuclear leucocytes, monocytes, macrophages and T lymphocytes in the dermal infiltrate were significantly lower in the dithranol/clobetasol‐treated site. Conclusions The addition of clobetasol‐17‐propionate enhanced the antipsoriatic efficacy of dithranol by interfering with T‐cell accumulation and epidermal proliferation. The addition of a corticosteroid reduced perilesional dithranol inflammation at the cellular level, although clinically detectable dithranol erythema was not reduced." @default.
• W2021983815 created "2016-06-24" @default.
• W2021983815 creator A5004654667 @default.
• W2021983815 creator A5047720665 @default.
• W2021983815 creator A5053488563 @default.
• W2021983815 creator A5056195835 @default.
• W2021983815 creator A5064403166 @default.
• W2021983815 creator A5082788366 @default.
• W2021983815 date "2001-07-01" @default.
• W2021983815 modified "2023-09-26" @default.
• W2021983815 title "The influence of a topical corticosteroid on short-contact high-dose dithranol therapy" @default.
• W2021983815 cites W1528737807 @default.
• W2021983815 cites W1966318098 @default.
• W2021983815 cites W1967227811 @default.
• W2021983815 cites W1985400448 @default.
• W2021983815 cites W1994365823 @default.
• W2021983815 cites W2005662159 @default.
• W2021983815 cites W2028894073 @default.
• W2021983815 cites W2042371014 @default.
• W2021983815 cites W2047961005 @default.
• W2021983815 cites W2079900290 @default.
• W2021983815 cites W2080695018 @default.
• W2021983815 cites W2091619900 @default.
• W2021983815 cites W2122663909 @default.
• W2021983815 cites W2154536753 @default.
• W2021983815 cites W2164251539 @default.
• W2021983815 cites W2167118789 @default.
• W2021983815 cites W2400045824 @default.
• W2021983815 cites W4252654242 @default.
• W2021983815 doi "https://doi.org/10.1046/j.1365-2133.2001.04282.x" @default.
• W2021983815 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/11453908" @default.
• W2021983815 hasPublicationYear "2001" @default.
• W2021983815 type Work @default.
• W2021983815 sameAs 2021983815 @default.
• W2021983815 citedByCount "13" @default.
• W2021983815 countsByYear W20219838152012 @default.
• W2021983815 countsByYear W20219838152013 @default.
• W2021983815 countsByYear W20219838152014 @default.
• W2021983815 countsByYear W20219838152021 @default.
• W2021983815 crossrefType "journal-article" @default.
• W2021983815 hasAuthorship W2021983815A5004654667 @default.
• W2021983815 hasAuthorship W2021983815A5047720665 @default.
• W2021983815 hasAuthorship W2021983815A5053488563 @default.
• W2021983815 hasAuthorship W2021983815A5056195835 @default.
• W2021983815 hasAuthorship W2021983815A5064403166 @default.
• W2021983815 hasAuthorship W2021983815A5082788366 @default.
• W2021983815 hasConcept C141071460 @default.
• W2021983815 hasConcept C16005928 @default.
• W2021983815 hasConcept C203014093 @default.
• W2021983815 hasConcept C2776110085 @default.
• W2021983815 hasConcept C2776804153 @default.
• W2021983815 hasConcept C2777063393 @default.
• W2021983815 hasConcept C2778903070 @default.
• W2021983815 hasConcept C2779121184 @default.
• W2021983815 hasConcept C2780564577 @default.
• W2021983815 hasConcept C2781156865 @default.
• W2021983815 hasConcept C2781463552 @default.
• W2021983815 hasConcept C71924100 @default.
• W2021983815 hasConceptScore W2021983815C141071460 @default.
• W2021983815 hasConceptScore W2021983815C16005928 @default.
• W2021983815 hasConceptScore W2021983815C203014093 @default.
• W2021983815 hasConceptScore W2021983815C2776110085 @default.
• W2021983815 hasConceptScore W2021983815C2776804153 @default.
• W2021983815 hasConceptScore W2021983815C2777063393 @default.
• W2021983815 hasConceptScore W2021983815C2778903070 @default.
• W2021983815 hasConceptScore W2021983815C2779121184 @default.
• W2021983815 hasConceptScore W2021983815C2780564577 @default.
• W2021983815 hasConceptScore W2021983815C2781156865 @default.
• W2021983815 hasConceptScore W2021983815C2781463552 @default.
• W2021983815 hasConceptScore W2021983815C71924100 @default.
• W2021983815 hasIssue "1" @default.
• W2021983815 hasLocation W20219838151 @default.
• W2021983815 hasLocation W20219838152 @default.
• W2021983815 hasOpenAccess W2021983815 @default.
• W2021983815 hasPrimaryLocation W20219838151 @default.
• W2021983815 hasRelatedWork W1966788665 @default.
• W2021983815 hasRelatedWork W1976660985 @default.
• W2021983815 hasRelatedWork W1987632618 @default.
• W2021983815 hasRelatedWork W2021983815 @default.
• W2021983815 hasRelatedWork W2049571946 @default.
• W2021983815 hasRelatedWork W2087850097 @default.
• W2021983815 hasRelatedWork W2134630607 @default.
• W2021983815 hasRelatedWork W2404809179 @default.
• W2021983815 hasRelatedWork W2462232127 @default.
• W2021983815 hasRelatedWork W5615460 @default.
• W2021983815 hasVolume "145" @default.
• W2021983815 isParatext "false" @default.
• W2021983815 isRetracted "false" @default.
• W2021983815 magId "2021983815" @default.
• W2021983815 workType "article" @default.